methysergide has been researched along with Substance-Related Disorders in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leccese, AP; Lyness, WH | 1 |
| Blum, K; Eubanks, JD; Schwertner, HA; Wallace, JE | 1 |
| Klein, HJ; Maxion, H | 1 |
| Wexler, DM | 1 |
| Rosenow, EC | 1 |
| Furukawa, H; Ishikawa, K; Kameyama, T; Nabeshima, T; Yamaguchi, K | 1 |
| Bueno, L; Primi, MP | 1 |
| Regli, F | 1 |
| Oswald, I | 1 |
| Friedman, AP | 1 |
| Falkowski, W; Lucas, RN | 1 |
| Retterstol, N | 1 |
1 trial(s) available for methysergide and Substance-Related Disorders
| Article | Year |
|---|---|
[Treatment of vascular headaches].
Topics: Adrenergic beta-Antagonists; Carbamazepine; Cerebrovascular Disorders; Clonidine; Ergotamine; Female; Headache; Hormones; Humans; Hydantoins; Methysergide; Phenacetin; Placebos; Pregnancy; Substance-Related Disorders; Vascular Headaches | 1973 |
11 other study(ies) available for methysergide and Substance-Related Disorders
| Article | Year |
|---|---|
The effects of putative 5-hydroxytryptamine receptor active agents on D-amphetamine self-administration in controls and rats with 5,7-dihydroxytryptamine median forebrain bundle lesions.
Topics: 5,7-Dihydroxytryptamine; Animals; Cyproheptadine; Dextroamphetamine; Fluoxetine; Humans; Male; Medial Forebrain Bundle; Methysergide; Neural Pathways; Quipazine; Rats; Rats, Inbred Strains; Serotonin; Substance-Related Disorders; Tryptophan | 1984 |
Enhancement of ethonol-induced withdrawal convulsions by blockade of 5-hydroxytryptamine receptors.
Topics: Animals; Ethanol; Humans; Male; Methysergide; Mice; Receptors, Serotonin; Seizures; Serotonin; Substance Withdrawal Syndrome; Substance-Related Disorders | 1976 |
[The pathogenesis and treatment of migraine (author's transl)].
Topics: Adult; Blood Coagulation Disorders; Ergotamine; Fibroma; Humans; Hypersensitivity; Inflammation; Methysergide; Middle Aged; Migraine Disorders; Parasympatholytics; Psychotropic Drugs; Serotonin; Substance-Related Disorders | 1978 |
Many parties hit in long drug misuse.
Topics: Female; Humans; Jurisprudence; Methysergide; Substance-Related Disorders; Vascular Diseases | 1978 |
Drug-induced pulmonary disease.
Topics: Adrenal Cortex Hormones; Analgesics; Anti-Bacterial Agents; Bronchial Spasm; Drug Hypersensitivity; Humans; Lung Diseases; Methysergide; Oxygen Inhalation Therapy; Pleural Effusion; Pneumonia, Aspiration; Pulmonary Fibrosis; Respiration; Respiratory Insufficiency; Substance-Related Disorders | 1977 |
Methysergide-induced precipitated withdrawal syndrome in phencyclidine-dependent rats.
Topics: Animals; Male; Methysergide; Phencyclidine; Rats; Rats, Inbred F344; Receptors, Serotonin; Substance Withdrawal Syndrome; Substance-Related Disorders | 1986 |
Effects of centrally administered naloxone on gastrointestinal myoelectrical activity in morphine-dependent rats.
Topics: Animals; Atropine; Clonidine; Digestive System; Electrophysiology; Enkephalin, Leucine; Gastrointestinal Motility; Indomethacin; Injections, Intraventricular; Injections, Subcutaneous; Male; Methysergide; Morphine; Naloxone; Phentolamine; Rats; Substance-Related Disorders; Tolazoline | 1987 |
Sleep.
Topics: Amobarbital; Appetite Depressants; Barbiturates; Dreams; Electroencephalography; Fenfluramine; Fluorine; Humans; Methysergide; Narcolepsy; Phenethylamines; Sleep; Sleep Stages; Sleep, REM; Substance-Related Disorders; Time Factors; Tranylcypromine; Tryptophan | 1969 |
Reflections on the treatment of headache.
Topics: Animals; Aspirin; Cyproheptadine; Ergotamine; Haplorhini; Headache; Hormones; Humans; Methysergide; Migraine Disorders; Muscle Contraction; Phenelzine; Propranolol; Substance-Related Disorders | 1972 |
Ergotamine and methysergide abuse in patients with migraine.
Topics: Adult; Drug Tolerance; Ergotamine; Female; Humans; Male; Methysergide; Middle Aged; Migraine Disorders; Psychophysiologic Disorders; Stress, Psychological; Substance Withdrawal Syndrome; Substance-Related Disorders | 1973 |
[Ergotamine addiction in migraine patients].
Topics: Administration, Oral; Drug Tolerance; Ergotamine; Humans; Injections; Methysergide; Migraine Disorders; Stress, Psychological; Substance-Related Disorders; Time Factors | 1973 |